Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on May 5, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print May 5, 2005, doi: 10.1161/01.ATV.0000168914.85107.64
A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/7/1370    most recent
01.ATV.0000168914.85107.64v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, W.
Right arrow Articles by Ihaya, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, W.
Right arrow Articles by Ihaya, A.

Submitted on October 25, 2004
Accepted on March 28, 2005

Thymidine Phosphorylase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 and p27KIP1

Wei Li ; Kuniyoshi Tanaka *; Koichi Morioka ; Takahiko Uesaka ; Narihisa Yamada ; Atsushi Takamori ; Mitsuteru Handa ; Sawaka Tanabe ; and Akio Ihaya

From the Second Department of Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

* To whom correspondence should be addressed. E-mail: kunitan{at}fmsrsa.fukui-med.ac.jp.

Objective--Thymidine phosphorylase (TP) reportedly promotes endothelial cell migration and induces heme oxygenase (HO)-1 expression. However, its effect on vascular smooth muscle cells (VSMCs) is poorly understood. In this study, we examined the effect of TP on VSMCs in vitro and in vivo.

Methods and Results--Phagemid vector encoding human TP gene was transfected into rat VSMCs, and a clone overexpressing TP was selected (C2). C2 showed a slower migration and proliferation than VSMCs cloned with empty vector (pC) under basal, serum-stimulated, and hypoxic conditions. This decrease in proliferation correlated with TP-induced HO-1 expression and was reversed by inhibitors of either TP or HO activity. Furthermore, in C2, the cyclin-dependent kinase inhibitor (p27KIP1) was much more abundant than in pC, and the cell cycle was arrested at the G1 phase. TP or HO activity inhibitors decreased p27KIP1 expression in C2 to the level seen in pC. Adventitial TP gene delivery significantly reduced neointimal VSMC migration and neointima formation in balloon-injured rat carotid arteries.

Conclusions--TP overexpression upregulated HO-1 expression and consequently increased p27KIP1 in cultured VSMCs, and inhibited VSMC migration and proliferation in vitro and in vivo. TP represents a promising target for treating vascular obstructive disease.


Key words: angiogenesis • gene therapy • thymidine phosphorylase • vascular obstructive disease • vascular smooth muscle cells




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
H. Yue, W. Li, R. Desnoyer, and S. S. Karnik
Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy
Cardiovasc Res, September 16, 2009; (2009) cvp285v2.
[Abstract] [Full Text] [PDF]